Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:JNJ
일자시간출처헤드라인심볼기업
2024/06/2102:07Business WireMore than 60 Law Firms Oppose J&J Prepack Bankruptcy SchemeNYSE:JNJJohnson and Johnson
2024/06/2021:00PR Newswire (US)TREMFYA® (guselkumab) studies underscore its potential to be the only IL-23 inhibitor to offer both subcutaneous and intravenous inductionNYSE:JNJJohnson and Johnson
2024/06/2019:55IH Market NewsTrump Media Resells Stocks and Warrants; KB Home Exceeds Q2 Expectations, and More NewsNYSE:JNJJohnson and Johnson
2024/06/1806:55Business WireBeasley Allen and Levin Papantonio: Leading Law Firms Seek Protection for Future Victims of Johnson & Johnson Talc ProductsNYSE:JNJJohnson and Johnson
2024/06/1721:00PR Newswire (US)Subcutaneous amivantamab Biologics License Application submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancerNYSE:JNJJohnson and Johnson
2024/06/1516:30PR Newswire (US)Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase 2 studyNYSE:JNJJohnson and Johnson
2024/06/1421:00PR Newswire (US)TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myelomaNYSE:JNJJohnson and Johnson
2024/06/1303:26Business WireTalc Plaintiffs File Motion for Temporary Restraining Order to Limit Johnson & Johnson’s Use of Bankruptcy StrategyNYSE:JNJJohnson and Johnson
2024/06/1220:19IH Market NewsParamount Ends Skydance Talks, Oracle Shares Surge 8.7% on New Partnerships, and More NewsNYSE:JNJJohnson and Johnson
2024/06/0706:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JNJJohnson and Johnson
2024/06/0706:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JNJJohnson and Johnson
2024/06/0520:41IH Market NewsApollo Buys 49% of Intel’s Irish Plant for $11bn, BlackRock and Citadel to Create Texas Exchange, and More NewsNYSE:JNJJohnson and Johnson
2024/06/0505:30Business WireJohnson & Johnson to Host Investor Conference Call on Second-Quarter ResultsNYSE:JNJJohnson and Johnson
2024/05/3121:45Business WireJohnson & Johnson Completes Acquisition of Shockwave MedicalNYSE:JNJJohnson and Johnson
2024/05/3006:48PR Newswire (US)Sarepta Therapeutics Set to Join S&P MidCap 400NYSE:JNJJohnson and Johnson
2024/05/2905:10Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:JNJJohnson and Johnson
2024/05/2820:35GlobeNewswire Inc.Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic DermatitisNYSE:JNJJohnson and Johnson
2024/05/2820:30Business WireJohnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic DermatitisNYSE:JNJJohnson and Johnson
2024/05/2301:05Business WireProposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc LitigationNYSE:JNJJohnson and Johnson
2024/05/2123:43Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNYSE:JNJJohnson and Johnson
2024/05/2106:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:JNJJohnson and Johnson
2024/05/2105:34Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NYSE:JNJJohnson and Johnson
2024/05/2105:01Edgar (US Regulatory)Form 8-K - Current reportNYSE:JNJJohnson and Johnson
2024/05/2022:31Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNYSE:JNJJohnson and Johnson
2024/05/1800:21Edgar (US Regulatory)Form 8-K - Current reportNYSE:JNJJohnson and Johnson
2024/05/1720:36IH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNYSE:JNJJohnson and Johnson
2024/05/1705:16Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JNJJohnson and Johnson
2024/05/1620:30Business WireJohnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis TreatmentNYSE:JNJJohnson and Johnson
2024/05/1506:01Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:JNJJohnson and Johnson
2024/05/1420:26IH Market NewsWalmart Corporate Job Cuts and Office Centralization, GameStop and AMC Surge, and More NewsNYSE:JNJJohnson and Johnson
 검색 관련기사 보기:NYSE:JNJ